An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. [electronic resource]
Producer: 20140818Description: 1-11 p. digitalISSN:- 1432-2072
- Antidepressive Agents, Second-Generation -- therapeutic use
- Benzazepines -- therapeutic use
- Bupropion -- therapeutic use
- Clinical Trials, Phase II as Topic -- methods
- Cross-Over Studies
- Drug Evaluation, Preclinical
- Feasibility Studies
- Humans
- Quinoxalines -- therapeutic use
- Research Design
- Smoking Cessation -- methods
- Validation Studies as Topic
- Varenicline
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
There are no comments on this title.
Log in to your account to post a comment.